Capital Income Builder - 529-F-1 | American Funds
Teva Pharmaceutical lowers guidance after profit miss | MarketScreener
Value line portfolio one
3 Warren Buffett Stocks on Sale | Morningstar
Morningstar Funds Trust - Morningstar Multi-Sector Bond Fund - Portfolio Holdings, AUM (13F, 13G)
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
Teva Is The Drug Industry's Comeback Story (NYSE:TEVA) | Seeking Alpha
Morningstar® Document Research℠
Teva Has Turned the Corner - GuruFocus.com
Investing Insights | Morningstar
Teva Pharmaceutical lowers guidance after profit miss | MarketScreener
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Morningstar Advisor - April/May 2010 - 63
TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical Industries Ltd. (NYSE) Stock
Teva- Pharmaceutical Industries (TEVA) | Better than Yahoo Finance | wallmine
Teva Bonds: 8.8% Yield To Maturity Understates Upside (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Is Turning A Corner (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries - GuruFocus.com
Markets Brief: What to Watch for in Q1 Earnings, CPI | Morningstar
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
DBRS Morningstar: Italian Banks Higher Net Interest Income To Offset Risks From Weaker Economic Prospects
Teva Pharmaceutical Industries - GuruFocus.com
The Vantagepoint Funds
